Nordicus Partners (NORD)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	46.13 k	46.13 k	46.13 k	46.13 k	46.13 k	46.13 k
Cash burn (monthly)	(no burn)	(no burn)	169.13 k	77.06 k	127.44 k	63.22 k
Cash used (since last report)	n/a	n/a	864.48 k	393.86 k	651.39 k	323.15 k
Cash remaining	n/a	n/a	-818.35 k	-347.73 k	-605.26 k	-277.01 k
Runway (months of cash)	n/a	n/a	-4.8	-4.5	-4.7	-4.4

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2024

NORD institutional ownership history Ownership history

38.1% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	3	3	–
Opened positions	0	2	EXIT
Closed positions	0	0
Increased positions	0	1	EXIT
Reduced positions	1	0	NEW

13F shares	Current	Prev Q	Change
Total value	0.00	0.00
Total shares	18.89 mm	37.96 mm	-50.2%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Alteral Therapeutics ApS	12.65 mm	$0.00	0.0%
Gk Partners ApS	3.35 mm	$0.00	-85.1%
JE Pitzner Holding ApS	2.89 mm	$0.00	0.0%

Largest transactions	Shares	Bought/sold	Change
Gk Partners ApS	3.35 mm	-19.07 mm	-85.1%
JE Pitzner Holding ApS	2.89 mm	0.00	0.0%
Alteral Therapeutics ApS	12.65 mm	0.00	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

NORD insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
15 Nov 24	Rouf Henrik	Stock Option Common stock	Grant	Acquire A	No	No	0	250,000	0.00	500,000
15 Nov 24	Rouf Henrik	Stock Option Common stock	Grant	Acquire A	No	No	3.25	250,000	812.50 k	250,000
15 Nov 24	Yankowitz Bennett J.	Stock Option Common stock	Grant	Acquire A	No	No	0	125,000	0.00	250,000
15 Nov 24	Yankowitz Bennett J.	Stock Option Common stock	Grant	Acquire A	No	No	3.25	125,000	406.25 k	125,000
12 Nov 24	Holding ApS ABCHill	Common stock	Other	Acquire J	No	No	0	903,829	0.00	916,329

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Press releases

From Benzinga Pro

Orocidin and Syngene Partner to Accelerate Biotech Innovation

20 Feb 25

BEVERLY HILLS, California, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Orocidin A/S ("Orocidin"), a subsidiary of Nordicus Partners Corporation (OTCQB:NORD) ("Nordicus" or the "Company"), a financial consulting company

Orocidin QR-01 Shows a Good Safety Profile in Preclinical Toxicity Study

18 Feb 25

BEVERLY HILLS, California, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Orocidin A/S ("Orocidin"), a subsidiary of Nordicus Partners Corporation (OTCQB:NORD) ("Nordicus" or the "Company"), a financial consulting company

Bio-Convert Develops QR-02, a Potential Breakthrough in the Treatment of Oral Leukoplakia

3 Feb 25

BEVERLY HILLS, California, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Bio-Convert ApS ("Bio-Convert"), a subsidiary of Nordicus Partners Corporation (OTCQB:NORD) ("Nordicus" or the "Company"), a financial consulting company

Oricidin Launches Groundbreaking Dental Gel for Long-Term Periodontitis Treatment

28 Jan 25

Nordicus Partners Corporation Announces Key Milestone in Development of Orocidin's Breakthrough Treatment for Periodontitis

14 Jan 25